Why the study?
Does the loss of Yap/Taz in cardiac fibroblasts attenuate adverse remodelling and improve cardiac function after myocardial infarction?
Does the loss of Yap/Taz in cardiac fibroblasts attenuate adverse remodelling and improve cardiac function after myocardial infarction?
Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodeling and improves cardiac function following myocardial infarction by modulating fibrotic and inflammatory pathways.
Answers are grounded in this paper and cite their sources.
Yap/Taz modulation may attenuate post-MI fibrosis in models; leaves open human translation and clinical testing.
We demonstrate that Yap/Taz play an important role in controlling MI-induced cardiac fibrosis by modulating fibroblasts proliferation, transdifferentiation into myofibroblasts, and fibroinflammatory programme.
No takes yet. Share an insight, caveat, or question.
Mia et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: